COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more
COSMOS HEALTH NEW DL-01 (V67A) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, COSMOS HEALTH NEW DL-01 (V67A) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
COSMOS HEALTH NEW DL-01 - Net Assets Trend (None–None)
This chart illustrates how COSMOS HEALTH NEW DL-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for COSMOS HEALTH NEW DL-01 (None–None)
The table below shows the annual net assets of COSMOS HEALTH NEW DL-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to COSMOS HEALTH NEW DL-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
COSMOS HEALTH NEW DL-01 Competitors by Market Cap
The table below lists competitors of COSMOS HEALTH NEW DL-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
D.T.C. Enterprise PCL
BK:DTCENT
|
$8.00 Million |
|
Accord Financial Corp
PINK:ACCFF
|
$8.00 Million |
|
Vintcom Technology PCL
BK:VCOM
|
$8.00 Million |
|
Cayman Tung Ling Co Ltd
TWO:2924
|
$8.00 Million |
|
Mistral Iberia Real Estate SOCIMI S.A.
MC:YMIB
|
$7.99 Million |
|
Zeo Energy Corp
NASDAQ:ZEO
|
$7.99 Million |
|
482520
KQ:482520
|
$7.99 Million |
|
Strategic Elements Ltd
AU:SOR
|
$7.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in COSMOS HEALTH NEW DL-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares COSMOS HEALTH NEW DL-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently COSMOS HEALTH NEW DL-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares COSMOS HEALTH NEW DL-01's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,497,081,556,090
- Average return on equity (ROE) among peers: 9.83%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| COSMOS HEALTH NEW DL-01 (V67A) | €- | N/A | N/A | $8.00 Million |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) | $17.65 Billion | 8.54% | 0.47x | $1.85 Billion |
| KIMIA FARMA -B- (HQP) | $7.41 Trillion | -0.17% | 1.48x | $78.59 Million |
| Asker Healthcare Group AB (I88) | $3.50 Billion | 10.28% | 2.75x | $1.38 Billion |
| TELES Informationstechnologien AG (TLIK) | $55.51 Million | 20.17% | 0.56x | $801.14K |
| Sinopharm Group Co. Ltd (X2S) | $51.27 Billion | 10.30% | 2.31x | $3.18 Billion |